Assessment of Forced Titration to Reach the Effective Dose for Good Glycemic Control in Lantus Treated Type 2 Patients.
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2010
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LANTIT
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 26 Nov 2010 Patient numbers amended from 240 to 241 as reported by ClinicalTrials.gov.
- 03 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.